ArticleFrontiers in oncology2020

FtH-Mediated ROS Dysregulation Promotes CXCL12/CXCR4 Axis Activation and EMT-Like Trans-Differentiation in Erythroleukemia K562 Cells.

Roberta Chirillo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.